| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, International Markets | EVP, Growth Markets Commercial
1 company
Nazzi Gianfranco is an EVP, International Markets at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $469K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2021 | TEVA Teva Pharmaceutical Industries Ltd | EVP, International Markets | Sale+OE | 12,935 | $10.58 | $136,909.21 | -100% | |
| Mar 3, 2021 | TEVA Teva Pharmaceutical Industries Ltd | EVP, International Markets | Sale+OE | 1,400 | $10.88 | $15,231.44 | -100% | |
| Mar 1, 2021 | TEVA Teva Pharmaceutical Industries Ltd | EVP, International Markets | Sale+OE | 75,587 | $10.87 | $821,924.63 | -55.6% | |
| Feb 9, 2021 | TEVA Teva Pharmaceutical Industries Ltd | EVP, International Markets | Sale+OE | 21,635 | $12.72 | $275,216.67 | -13.5% | |
| Mar 17, 2020 | TEVA Teva Pharmaceutical Industries Ltd | EVP, International Markets | Sale+OE | 345 | $7.17 | $2,474.13 | -1.7% | |
| Mar 3, 2020 | TEVA Teva Pharmaceutical Industries Ltd | EVP, International Markets | Sale+OE | 548 | $11.77 | $6,447.60 | -2.8% | |
| Feb 10, 2020 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 4,155 | $12.24 | $50,864.26 | -18.4% | |
| Sep 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 962 | $7.82 | $7,523.13 | -8.3% | |
| Mar 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 320 | $16.64 | $5,326.27 | -3.4% | |
| Mar 12, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Growth Markets Commercial | Sale+OE | 325 | $15.69 | $5,099.19 | -3.7% |